시장보고서
상품코드
2057522

BNP 및 NT-proBNP 시장 : 기회 및 전략(-2035년)

BNP And NT-proBNP Global Market Opportunities And Strategies To 2035

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 347 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,867,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,927,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 12,986,000
※ 부가세 별도
한글목차
영문목차

세계의 BNP 및 NT-proBNP 시장은 2020년에 12억 4,550만 달러로 평가되었고, 2025년까지 연평균 복합 성장률(CAGR) 12.00% 이상으로 성장했습니다.

BNP 및 NT-proBNP 시장은 혈액 샘플중 BNP 및 NT-proBNP 농도를 정량적으로 측정하기 위해서 사용되는 면역측정법에 근거한 검사 키트, 시약, 교정액, 컨트롤 및 분석 장비 개발, 제조, 제공을 통해서 기업(조직, 개인 사업주, 파트너십)이 낳는 매출로 구성되어 있습니다. 이러한 검사는 주로, 병원, 구급 부문, 외래 진료소 및 전문 심장 센터에서 호흡 곤란, 부종, 피로등의 증상을 나타내는 환자를 평가하기 위해서, 순환기 전문의, 구급의, 내과의 및 일반 개업의에 의해서 사용되고 있습니다. 이것들은 급성기 의료 현장에서의 신속한 트리아지나, 만성기 의료 현장에서의 질환 모니터링 및 리스크 층 별 화에 활용되고 있습니다.

조기 진단 및 예방적 심장병학에 대한 인식 제고

과거 BNP 및 NT-proBNP 시장은 조기 진단 및 예방적 심장병학에 대한 인식이 높아짐에 따라 크게 성장했습니다. 조기진단 및 예방심장병학은 심각한 질환이 발생하기 전에 임상 스크리닝, 바이오마커 및 위험도 평가 도구를 사용하여 심혈관 위험 및 초기 단계의 심장질환을 적극적으로 확인하고 관리하는 것을 말합니다. 이는 주로 전 세계적으로 심부전 및 심장병 위험군에 대한 부담이 증가함에 따라 정기적인 검진과 조기 임상적 개입을 촉진하고 있기 때문으로 분석됩니다. BNP 및 NT-proBNP 검사는 바이오마커를 기반으로 심장 부하 및 기능 장애를 신속하게 감지하여 임상의가 위험을 계층화하고 적시에 예방적 치료를 시작할 수 있도록 함으로써 조기 진단 및 예방적 심장병학을 지원합니다. 예를 들어, 호주 정부 기관인 호주보건복지연구원(AIHW)에 따르면, 2021-2022년 호주에서 관상동맥질환으로 인한 입원 건수는 약 14만 8,000건으로 전체 입원환자의 1.3%, 심혈관질환 관련 입원 건수의 26%를 차지합니다. 또한, 2022년에는 관상동맥성 심장질환이 약 1만 8,600명의 사망원인이 되어 전국 사망자의 약 9.8%를 차지하였습니다. 따라서 지난 몇 년 동안 BNP 및 NT-proBNP 시장은 조기 진단 및 예방적 심장병학에 대한 인식이 높아짐에 따라 크게 성장해 왔습니다.

생명공학, 유전체학, 정밀의학, 바이오테크놀러지

BNP 및 NT-proBNP 시장의 기업들은 진단 정확도를 높이고 심혈관 위험을 조기에 발견하기 위해 생명공학, 유전체학 및 정밀 의학에 점점 더 많은 관심을 기울이고 있습니다. 이를 통해 보다 민감한 바이오마커 검사 및 개인화된 검사 전략 개발을 지원하고, 환자 계층화를 개선하고 보다 정확한 임상적 의사결정을 내릴 수 있도록 지원하며, 정밀하고 데이터 기반의 심장 치료 솔루션을 강화합니다. 생명공학, 유전체학 및 정밀의학은 BNP 및 NT-proBNP 검사를 지원하여 심부전 및 관련 심장 질환을 조기에 정확하게 감지할 수 있는 고감도 바이오마커 검사 및 고급 분자진단 플랫폼을 가능하게 함으로써 심부전 및 관련 심장 질환의 조기 진단을 개선하고 있습니다. 예를 들어, 2024년 4월 인도에 본사를 둔 제약회사 Roche Diagnostics India Pvt Ltd는 심혈관 질환(CVD) 위험이 있는 당뇨병 환자를 대상으로 NT-proBNP 검사를 시작했습니다. 이 제품은 심혈관 합병증의 조기 발견을 돕고 적시에 임상적 개입을 가능하게 하며, 고위험군 당뇨병 환자군의 일상적인 검진 및 신속한 위험 평가를 목적으로 설계되어 예방적 심장병학 검진 및 통합적 바이오마커 기반의 질병 관리를 일신하는 것입니다.

세계 BNP 및 NT-proBNP 시장은 상대적으로 집중되어 있으며, 주요 기업들이 시장에서 사업을 전개하고 있습니다. 2024년 기준, 시장 상위 10개 경쟁업체가 전체 시장의 34.5%를 차지하고 있습니다.

자주 묻는 질문

  • BNP 및 NT-proBNP 시장 규모는 어떻게 되나요?
  • BNP 및 NT-proBNP 검사는 주로 어떤 용도로 사용되나요?
  • BNP 및 NT-proBNP 시장의 성장 요인은 무엇인가요?
  • BNP 및 NT-proBNP 시장에서 생명공학과 정밀 의학의 역할은 무엇인가요?
  • BNP 및 NT-proBNP 시장의 주요 기업은 어디인가요?
  • BNP 및 NT-proBNP 시장의 경쟁 구도는 어떤가요?

목차

제1장 주요 요약

제2장 목차

제3장 표 리스트

제4장 그래프 리스트

제5장 보고서 구성

제6장 시장 특징

제7장 BNP 및 NTproBNP 시장 : 주요 제품 개요

제8장 세계의 BNP 및 NTproBNP 시장 : 시장 매력 평가 및 분석

제9장 주요 시장 동향

제10장 세계의 BNP 및 NTproBNP 시장 : 성장 분석 및 전략적 분석 프레임워크

제11장 세계의 BNP 및 NTproBNP 시장 : 규모 및 성장 분석

제12장 세계의 BNP 및 NTproBNP 시장 : 총잠재 시장(TAM) 분석

제13장 세계의 BNP 및 NTproBNP 시장 : 시장 세분화

제14장 BNP 및 NTproBNP 시장 : 지역별 및 국가별 분석

제15장 아시아태평양 시장

제16장 동남아시아 시장

제17장 북미 시장

제18장 서유럽 시장

제19장 남미 시장

제20장 동유럽 시장

제21장 중동 시장

제22장 아프리카 시장

제23장 경쟁 구도 및 기업 개요

제24장 기타 주요 기업 및 혁신 기업

제25장 경쟁 벤치마킹

제26장 경쟁 대시보드

제27장 BNP 및 NTproBNP 시장 : 기업 평가 매트릭스

제28장 시장에서 주목 받는 스타트업

제29장 주요 인수합병(M&A)

제30장 BNP 및 NTproBNP 시장 최근 동향

제31장 기회와 전략

제32장 BNP 및 NT-proBNP 시장 : 결론과 제안

제33장 부록

AJY

The BNP and NT-proBNP market consists of revenues generated by entities (organizations, sole traders and partnerships) through the development, manufacture and provision of immunoassay-based test kits, reagents, calibrators, controls and analyzer systems used to quantitatively measure BNP and NT-proBNP levels in blood samples. These tests are primarily used by cardiologists, emergency physicians, internists and general practitioners in hospitals, emergency departments, outpatient clinics and specialized cardiac centers to evaluate patients presenting with symptoms such as dyspnea, edema and fatigue. They are used in acute settings for rapid triage and in chronic care settings for disease monitoring and risk stratification.

The global BNP and NTproBNP market was valued at $1,245.5 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 12.00%.

Rising Awareness Of Early Diagnosis And Preventive Cardiology

During the historic period, the BNP and NT-proBNP market was significantly driven by the rising awareness of early diagnosis and preventive cardiology. Early diagnosis and preventive cardiology refer to the proactive identification and management of cardiovascular risk and early-stage heart conditions using clinical screening, biomarkers and risk assessment tools before severe disease develops. It is increasing primarily due to the growing global burden of heart failure and cardiac risk populations, which is driving routine screening and earlier clinical intervention. BNP and NT-proBNP testing supports early diagnosis and preventive cardiology by enabling rapid biomarker-based detection of cardiac stress and dysfunction, allowing clinicians to stratify risk and initiate timely preventive treatment. For instance, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, In 2021-22, Australia recorded about 148,000 hospitalizations with coronary heart disease as the main diagnosis, representing 1.3% of all hospital admissions and 26% of cardiovascular disease-related hospitalizations. In 2022, coronary heart disease was also the underlying cause of roughly 18,600 deaths, accounting for about 9.8% of all deaths nationwide. Therefore, the BNP and NT-proBNP market was significantly driven by the rising awareness of early diagnosis and preventive cardiology in the historic period.

Biotechnology, Genomics And Precision Medicine

Companies in the BNP and NT-proBNP market are increasingly prioritizing biotechnology, genomics and precision medicine to enhance diagnostic accuracy and early cardiovascular risk detection, supporting the development of more sensitive biomarker assays and personalized testing strategies, enabling improved patient stratification and more targeted clinical decision-making and strengthening precision-based and data-driven cardiac care solutions. Biotechnology, genomics and precision medicine support BNP and NT-proBNP testing by enabling highly sensitive biomarker assays and advanced molecular diagnostic platforms that improve early and accurate detection of heart failure and related cardiac conditions. For instance, in April 2024, Roche Diagnostics India Pvt Ltd, an India-based pharmaceutical company, launched an NT-proBNP test for diabetes patients at risk of CVD to support early identification of cardiovascular complications and enable timely clinical intervention, with the test designed for routine screening and faster risk evaluation in high-risk diabetic populations, reshaping preventive cardiology screening and integrated biomarker-based disease management.

The global BNP and NTproBNP market is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 34.5% of the total market in 2024.

BNP And NT-proBNP Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global BNP and NT-proBNP market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market forBNP and NT-proBNP? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The BNP and NT-proBNP market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the BNP and NT-proBNP; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
  • Market Segmentation Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by type, by location of testing and by application in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Recent Developments Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for BNP and NT-proBNP providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: BNP (Brain Natriuretic Peptide); NT-proBNP (N-terminal Pro-B-Type Natriuretic Peptide)
  • 2) By Location Of Testing: Point Of Care Testing; Laboratory Testing
  • 3) By Application: Myocardial Infarction; Congestive Heart Failure; Acute Coronary Syndrome (ACS); Other Applications
  • Companies Mentioned: Abbott Laboratories; F Hoffman La Roche Ltd; Siemens Healthineers; bioMerieux SA; QuidelOrtho Corp.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; Taiwan; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; South East Asia, Western Europe;Eastern Europe; North America; South America, Middle East, Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; BNP and NT-proBNP indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Dashboard

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 BNP And NT-proBNP Market Definition And Segmentations
  • 6.4 Market Segmentation By Type (BNP (Brain Natriuretic Peptide) And NT-proBNP (N-terminal Pro-B-Type Natriuretic Peptide))
  • 6.5 Market Segmentation By Location Of Testing (Point Of Care Testing And Laboratory Testing)
  • 6.6 Market Segmentation By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS) And Other Applications)

7 BNP And NTproBNP Market, Overview Of Key Products

8 Global BNP And NTproBNP Market Attractiveness Scoring And Analysis

  • 8.1 Overview Of Market Attractiveness Framework
  • 8.2 Quantitative Scoring Methodology
  • 8.3 Market Attractiveness Scoring And Interpretation
  • 8.4 Factor-Wise Evaluation
    • 8.4.1 Growth Potential
    • 8.4.2 Competitive Dynamics
    • 8.4.3 Strategic Fit
    • 8.4.4 Risk Profile
  • 8.5 Strategic Implications And Recommendations
    • 8.5.1 Strategic Implications
    • 8.5.2 Strategic Recommendations

9 Major Market Trends

  • 9.1 Key Technologies & Future Trends
    • 9.1.1 Biotechnology, Genomics And Precision Medicine
    • 9.1.2 Artificial Intelligence And Autonomous Intelligence
    • 9.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 9.1.4 Internet of Things (IoT), Smart Infrastructure And Connected Ecosystems
    • 9.1.5 Industry 4.0 And Intelligent Manufacturing
  • 9.2 Major Trends
    • 9.2.1 Rapid Screening Bioassays And New Cardiac Assay Launches Strengthening The Cardiac Diagnostics Market

10 Global BNP And NTproBNP Growth Analysis And Strategic Analysis Framework

  • 10.1 Global BNP And NTproBNP PESTEL Analysis
    • 10.1.1 Political
    • 10.1.2 Economic
    • 10.1.3 Social
    • 10.1.4 Technological
    • 10.1.5 Environmental
    • 10.1.6 Legal
  • 10.2 Analysis Of End Users (B2B)
    • 10.2.1 Hospitals
    • 10.2.2 Clinical And Diagnostic Laboratories
    • 10.2.3 Ambulatory Care Centers
    • 10.2.4 Academic And Research Institutions
    • 10.2.5 Other End Users

11 Global BNP And NTproBNP Market Size And Growth Analysis

  • 11.1 Historic Market Growth, 2020 - 2025, Value ($ Million)
    • 11.1.1 Market Drivers 2020 - 2025
    • 11.1.2 Market Restraints 2020 - 2025
  • 11.2 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
  • 11.3 Forecast Growth Contributors/Factors
    • 11.3.1 Quantitative Growth Contributors
    • 11.3.2 Drivers
    • 11.3.3 Restraints

12 Global BNP And NTproBNP Total Addressable Market (TAM) Analysis

  • 12.1 Definition And Scope of Total Addressable Market (TAM)
  • 12.2 Methodology And Assumptions
    • 12.2.1 Total Addressable Market for the BNP And NTproBNP Market - Business to Business (B2B)
    • 12.2.2 TAM Comparison Analysis

13 Global BNP And NTproBNP Market Segmentation

  • 13.1 Global BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.2 Global BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.3 Global BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.4 Global BNP And NTproBNP Market, Sub-Segmentation Of BNP (Brain Natriuretic Peptide), By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.5 Global BNP And NTproBNP Market, Sub-Segmentation Of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide), By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

14 BNP And NTproBNP Market, Regional and Country Analysis

  • 14.1 Global BNP And NTproBNP Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.2 Global BNP And NTproBNP Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

15 Asia-Pacific Market

  • 15.1 Asia-Pacific Market Summary
  • 15.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 15.3 Asia-Pacific BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.4 Asia-Pacific BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.5 Asia-Pacific BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.6 China Market
    • 15.6.1 China Market Summary
    • 15.6.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 15.7 China BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.8 China BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.9 China BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.10 India Market
  • 15.11 India BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.12 India BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.13 India BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.14 Japan Market
    • 15.14.1 Japan Market Summary
    • 15.14.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 15.15 Japan BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.16 Japan BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.17 Japan BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.18 Australia Market
  • 15.19 Australia BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.20 Australia BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.21 Australia BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.22 South Korea Market
    • 15.22.1 South Korea Market Summary
    • 15.22.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 15.23 South Korea BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.24 South Korea BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.25 South Korea BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.26 Taiwan Market
  • 15.27 Taiwan Market Summary
    • 15.27.1 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 15.28 Taiwan BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.29 Taiwan BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.30 Taiwan BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 South East Asia Market

  • 16.1 South East Asia Market Summary
  • 16.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 16.2.1 South East Asia BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.2.2 South East Asia BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.2.3 South East Asia BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.3 Indonesia Market
    • 16.3.1 Indonesia BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.3.2 Indonesia BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.3.3 Indonesia BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 North America Market

  • 17.1 North America Market Summary
  • 17.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 17.3 North America BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.4 North America BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.5 North America BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.6 USA Market
    • 17.6.1 USA Market Summary
    • 17.6.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 17.7 USA BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.8 USA BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.9 USA BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.10 Canada Market
    • 17.10.1 Canada Market Summary
    • 17.10.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 17.11 Canada BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.12 Canada BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.13 Canada BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 Western Europe Market

  • 18.1 Western Europe Market Summary
  • 18.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 18.3 Western Europe BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.4 Western Europe BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.5 Western Europe BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6 UK Market
  • 18.7 UK BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.8 UK BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.9 UK BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.10 Germany Market
  • 18.11 Germany BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.12 Germany BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.13 Germany BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.14 France Market
  • 18.15 France BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.16 France BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.17 France BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.18 Italy Market
  • 18.19 Italy BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.20 Italy BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.21 Italy BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.22 Spain Market
  • 18.23 Spain BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.24 Spain BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.25 Spain BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 South America Market

  • 19.1 South America Market Summary
  • 19.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 19.3 South America BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.4 South America BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.5 South America BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.6 Brazil Market
  • 19.7 Brazil BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.8 Brazil BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.9 Brazil BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

20 Eastern Europe Market

  • 20.1 Eastern Europe Market Summary
  • 20.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 20.3 Eastern Europe BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.4 Eastern Europe BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.5 Eastern Europe BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.6 Russia Market
  • 20.7 Russia BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.8 Russia BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.9 Russia BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

21 Middle East Market

  • 21.1 Middle East Market Summary
  • 21.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 21.3 Middle East BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.4 Middle East BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.5 Middle East BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

22 Africa Market

  • 22.1 Africa Market Summary
  • 22.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 22.3 Africa BNP And NTproBNP Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.4 Africa BNP And NTproBNP Market, Segmentation By Location Of Testing, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.5 Africa BNP And NTproBNP Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

23 Competitive Landscape And Company Profiles

  • 23.1 BNP And NTproBNP Market Competitive Landscape And & Market Share 2024
    • 23.1.1 Top 10 Companies (Ranked by revenue/share)
  • 23.2 Company Profiles
  • 23.3 Abbott Laboratories (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 23.4 F Hoffman La Roche Ltd (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 23.5 Siemens Healthineers (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 23.6 bioMerieux SA (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 23.7 QuidelOrtho Corp (Company Overview, Products and Services, Business Strategy, Financial Overview)

24 Other Major And Innovative Companies

  • 24.1 Beckman Coulter (Danaher) (Company Overview, Products and Services)
  • 24.2 Randox Laboratories Ltd. (Company Overview, Products and Services)
  • 24.3 Bio-Techne Co. (Company Overview, Products and Services)
  • 24.4 Getein Biotech Inc. (Company Overview, Products and Services)
  • 24.5 Tosoh Corporation (Company Overview, Products and Services)
  • 24.6 Thermo Fisher Scientific Inc. (Company Overview, Products and Services)
  • 24.7 Radiometer Medical ApS (Company Overview, Products and Services)
  • 24.8 Autobio Diagnostics (Company Overview, Products and Services)
  • 24.9 Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (Company Overview, Products and Services)
  • 24.10 CTK Biotech Inc. (Company Overview, Products and Services)
  • 24.11 Creative Diagnostics (Company Overview, Products and Services)
  • 24.12 RayBiotech Life Inc. (Company Overview, Products and Services)
  • 24.13 Response Biomedical Corp. (Company Overview, Products and Services)
  • 24.14 Xiamen Biotime Biotechnology Co. Ltd. (Company Overview, Products and Services)
  • 24.15 Scripps Laboratories Inc. (Company Overview, Products and Services)

25 Competitive Benchmarking

26 Competitive Dashboard

27 BNP And NTproBNP Market - Company Scoring Matrix

  • 27.1 Innovation and Brand Leaders
  • 27.2 Brand-Driven Traditionalists
  • 27.3 Niche or Regional Followers
  • 27.4 Emerging Innovators

28 Upcoming Startups In the Market

29 Key Mergers And Acquisitions

  • 29.1 Roche completed acquisition of LumiraDx

30 Recent Developments In The BNP And NTproBNP Market

  • 30.1 Abbott Receives FDA Clearance For Alere NT-Probnp Assay On Alinity I Platform

31 Opportunities And Strategies

  • 31.1 Global BNP And NTproBNP Market In 2030 - Countries Offering Most New Opportunities
  • 31.2 Global BNP And NTproBNP Market In 2030 - Segments Offering Most New Opportunities
  • 31.3 Global BNP And NTproBNP Market In 2030 - Growth Strategies
    • 31.3.1 Market Trend Based Strategies
    • 31.3.2 Competitor Strategies

32 BNP And NT-proBNP Market, Conclusions And Recommendations

  • 32.1 Conclusions
  • 32.2 Recommendations
    • 32.2.1 Product
    • 32.2.2 Place
    • 32.2.3 Price
    • 32.2.4 Promotion
    • 32.2.5 People

33 Appendix

  • 33.1 Geographies Covered
  • 33.2 Market Data Sources
  • 33.3 Research Methodology
  • 33.4 Currencies
  • 33.5 The Business Research Company
  • 33.6 Copyright and Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기